Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqCM - Delayed Quote USD

Nexalin Technology, Inc. (NXL)

Compare
1.8100
-0.2000
(-9.95%)
At close: April 3 at 4:00:00 PM EDT
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for NXL

Recent News: NXL

View More
Nexalin Technology Enrolls First Patients and Advances Toward Treatment in UCSD Clinical Trial

Nexalin Technology Enrolls First Patients and Advances Toward Treatment in UCSD Clinical Trial
GlobeNewswire yesterday
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on April 3

Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on April 3
GlobeNewswire 8 days ago

Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
ACCESS Newswire 20 days ago
Nexalin Technology Receives Notice of Allowance from the USPTO for Patent Covering Deep Intracranial Frequency Stimulation (DIFS™) Technology for Opioid and Other Substance Use Disorders

Nexalin Technology Receives Notice of Allowance from the USPTO for Patent Covering Deep Intracranial Frequency Stimulation (DIFS™) Technology for Opioid and Other Substance Use Disorders
GlobeNewswire last month
UCSD begins trial with Nexalin’s Halo Clarity device for mTBI and PTSD

UCSD begins trial with Nexalin’s Halo Clarity device for mTBI and PTSD
Medical Device Network last month
Nexalin Technology Announces Initiation of Patient Recruitment for UCSD’s TBI & PTSD Clinical Study Following IRB Approval

Nexalin Technology Announces Initiation of Patient Recruitment for UCSD’s TBI & PTSD Clinical Study Following IRB Approval
GlobeNewswire last month
Nexalin Technology Welcomes General Wesley Clark to Military & Government Advisory Board

Nexalin Technology Welcomes General Wesley Clark to Military & Government Advisory Board
GlobeNewswire last month
Nexalin Technology Announces UCSD IRB Approval for use of HALO™ Clarity in Clinical Trials for mTBI and PTSD Treatment

Nexalin Technology Announces UCSD IRB Approval for use of HALO™ Clarity in Clinical Trials for mTBI and PTSD Treatment
GlobeNewswire last month
Nexalin Appointed as Industry Co-Chair of National TBI Registry Coalition

Nexalin Appointed as Industry Co-Chair of National TBI Registry Coalition
GlobeNewswire last month
Nexalin’s Breakthrough DIFS™ Neurostimulation Device Demonstrates Reduction in Blood Pressure while Enhancing Mental Health According to New Landmark Study

Nexalin’s Breakthrough DIFS™ Neurostimulation Device Demonstrates Reduction in Blood Pressure while Enhancing Mental Health According to New Landmark Study
GlobeNewswire last month
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session, Today, January 23

Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session, Today, January 23
GlobeNewswire 2 months ago
View More

Related Tickers

NUWE Nuwellis, Inc.
0.9600
-4.00%
 
IRIX IRIDEX Corporation
0.9500
-7.77%
 
CLPT ClearPoint Neuro, Inc.
12.14
-7.30%
 
RPID Rapid Micro Biosystems, Inc.
2.5500
-7.94%
 
IINN Inspira Technologies Oxy B.H.N. Ltd.
0.6236
-6.80%
 
RCEL AVITA Medical, Inc.
7.51
-3.84%
 
CODX Co-Diagnostics, Inc.
0.3230
-9.78%
 
SEQUA.BR Sequana Medical NV
0.9100
-5.01%
 
BMRA Biomerica, Inc.
0.5380
-5.40%
 
AIMD Ainos, Inc.
0.5449
+1.85%
 
Waiting for permission
Allow microphone access to enable voice search

Try again.